Korea's Supreme Court Upholds Lower Courts' Ruling against Pfizer's Lipitor Patent Extension
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Ending nearly two years of court battles over the patent extension of Pfizer's cholesterol drug Lipitor, South Korea's Supreme Court upheld the lower courts' rulings in favor of six local Korean pharmaceutical companies that have been selling generics of Lipitor (atorvastatin)